Patents by Inventor Beatriz Mothe Pujadas

Beatriz Mothe Pujadas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating HIV-1 infection utilizing a multiepitope T cell immunogen comprising Gag, Pol, Vif, and Nef epitopes
    Patent number: 11919926
    Abstract: The present invention relates to novel immunogens based on overlapping peptides (OLPs) and peptides derived therefrom useful for the prevention and treatment of AIDS and its related opportunistic diseases. The invention also relates to isolated nucleic acids, vectors and host cells expressing these immunogens as well as vaccines including said immunogens.
    Type: Grant
    Filed: April 29, 2021
    Date of Patent: March 5, 2024
    Assignees: ESTEVE PHARMACEUTICALS, S.A., FUNDACIO PRIVADA INSTITUT DE RECERCA DE LA SIDA—CAIXA
    Inventors: Christian Brander, Beatriz Mothe Pujadas, Anuska Llano
  • Prime/boost immunization regimen against HIV-1 utilizing a multiepitope T cell immunogen comprising Gag, Pol, Vif, and Nef epitopes
    Patent number: 11666651
    Abstract: The present invention relates to immunogenic therapies for the treatment or prevention of a human immunodeficiency virus (HIV) infection or a disease associated with an HIV infection.
    Type: Grant
    Filed: November 12, 2020
    Date of Patent: June 6, 2023
    Assignee: AELIX Therapeutics, S.L.
    Inventors: Christian Brander, Beatriz Mothe-Pujadas
  • DOSAGE REGIMENS FOR VACCINES
    Publication number: 20220226459
    Abstract: The present invention relates to immunogenic therapies for the treatment or prevention of a human immunodeficiency virus (HIV) infection or a disease associated with an HIV infection.
    Type: Application
    Filed: May 21, 2020
    Publication date: July 21, 2022
    Inventors: CHRISTIAN BRANDER, BEATRIZ MOTHE PUJADAS, IAN MCGOWAN
  • COMBINATION OF A TLR7 MODULATING COMPOUND AND AN HIV VACCINE
    Publication number: 20220218711
    Abstract: The present disclosure describes methods, compositions, and kits related to the combination of a TLR7 modulating compound and an HIV vaccine. The combination can be used in a method of treating or preventing an HIV infection in a human.
    Type: Application
    Filed: May 21, 2020
    Publication date: July 14, 2022
    Inventors: Romas Geleziunas, Devi Sengupta, Christian Brander, Beatriz Mothe Pujadas, Ian McGowan
  • Method of treating HIV-1 infection utilizing a multiepitope T cell immunogen comprising gag, pol, vif and nef epitopes
    Patent number: 11325946
    Abstract: The present invention relates to novel immunogens based on overlapping peptides (OLPs) and peptides derived therefrom useful for the prevention and treatment of AIDS and its related opportunistic diseases. The invention also relates to isolated nucleic acids, vectors and host cells expressing these immunogens as well as vaccines including said immunogens.
    Type: Grant
    Filed: May 3, 2018
    Date of Patent: May 10, 2022
    Assignees: LABORATORIOS DEL DR. ESTEVE S.A., FUNDACIÓ PRIVADA INSTITUT DE RECERCA DE LA SIDE—CAIXA
    Inventors: Christian Brander, Beatriz Mothe Pujadas, Anuska Llano
  • IMMUNOGENS FOR HIV VACCINATION
    Publication number: 20210246172
    Abstract: The present invention relates to novel immunogens based on overlapping peptides (OLPs) and peptides derived therefrom useful for the prevention and treatment of AIDS and its related opportunistic diseases. The invention also relates to isolated nucleic acids, vectors and host cells expressing these immunogens as well as vaccines including said immunogens.
    Type: Application
    Filed: April 29, 2021
    Publication date: August 12, 2021
    Inventors: Christian BRANDER, Beatriz Mothe PUJADAS, Anuska LLANO
  • DOSAGE REGIMENS FOR VACCINES
    Publication number: 20210145961
    Abstract: The present invention relates to immunogenic therapies for the treatment or prevention of a human immunodeficiency virus (HIV) infection or a disease associated with an HIV infection.
    Type: Application
    Filed: November 12, 2020
    Publication date: May 20, 2021
    Inventors: Christian BRANDER, Beatriz MOTHE-PUJADAS
  • Immunogens for HIV vaccination
    Patent number: 10815278
    Abstract: The present invention relates to novel immunogens based on overlapping peptides (OLPs) and peptides derived therefrom useful for the prevention and treatment of AIDS and its related opportunistic diseases. The invention also relates to isolated nucleic acids, vectors and host cells expressing these immunogens as well as vaccines including said immunogens.
    Type: Grant
    Filed: September 28, 2017
    Date of Patent: October 27, 2020
    Assignees: Laboratorios del Dr. Esteve S.A., Fundació Privada Institut de Recerca de La Sida—Caixa
    Inventors: Christian Brander, Beatriz Mothe Pujadas, Anuska Llano
  • IMMUNOGENS FOR HIV VACCINATION
    Publication number: 20190055289
    Abstract: The present invention relates to novel immunogens based on overlapping peptides (OLPs) and peptides derived therefrom useful for the prevention and treatment of AIDS and its related opportunistic diseases. The invention also relates to isolated nucleic acids, vectors and host cells expressing these immunogens as well as vaccines including said immunogens.
    Type: Application
    Filed: May 3, 2018
    Publication date: February 21, 2019
    Inventors: Christian BRANDER, Beatriz MOTHE PUJADAS, Anuska LLANO
  • IMMUNOGENS FOR HIV VACCINATION
    Publication number: 20180170971
    Abstract: The present invention relates to novel immunogens based on overlapping peptides (OLPs) and peptides derived therefrom useful for the prevention and treatment of AIDS and its related opportunistic diseases. The invention also relates to isolated nucleic acids, vectors and host cells expressing these immunogens as well as vaccines including said immunogens.
    Type: Application
    Filed: September 28, 2017
    Publication date: June 21, 2018
    Inventors: Christian BRANDER, Beatriz MOTHE PUJADAS, Anuska LLANO
  • Immunogens for HIV vaccination
    Patent number: 9988425
    Abstract: The present invention relates to novel immunogens based on overlapping peptides (OLPs) and peptides derived therefrom useful for the prevention and treatment of AIDS and its related opportunistic diseases. The invention also relates to isolated nucleic acids, vectors and host cells expressing these immunogens as well as vaccines including the immunogens.
    Type: Grant
    Filed: January 28, 2013
    Date of Patent: June 5, 2018
    Assignees: Laboratories Del Dr. Esteve S.A., Fundació Privada Institut De Recerca De La Sida—CAIXA
    Inventors: Christian Brander, Beatriz Mothe Pujadas, Anuska Llano
  • HIGHLY IMMUNOGENIC HIV P24 SEQUENCES
    Publication number: 20170202950
    Abstract: The invention relates to peptides comprising part or all of a conserved element within a Center-of-Tree (COT) sequence derived from a family of polypeptides encoded by naturally occurring variants of HIV. The invention also relates to immunogenic compositions and vaccines comprising said peptides. The invention also relates to methods for the identification of HIV controller patients based on the detection of the T cells of the patient to mount a cytotoxic T cell response against said peptides and to methods for the identification of immunogenic peptides within a family of variant polypeptides.
    Type: Application
    Filed: March 20, 2017
    Publication date: July 20, 2017
    Inventors: Beatriz MOTHE PUJADAS, Christian BRANDER, James I. MULLINS
  • IMMUNOGENS FOR HIV VACCINATION
    Publication number: 20150050310
    Abstract: The present invention relates to novel immunogens based on overlapping peptides (OLPs) and peptides derived therefrom useful for the prevention and treatment of AIDS and its related opportunistic diseases. The invention also relates to isolated nucleic acids, vectors and host cells expressing these immunogens as well as vaccines including the immunogens.
    Type: Application
    Filed: January 28, 2013
    Publication date: February 19, 2015
    Inventors: Christian Brander, Beatriz Mothe Pujadas, Anuska Llano
  • HIGHLY IMMUNOGENIC HIV P24 SEQUENCES
    Publication number: 20130302364
    Abstract: The invention relates to peptides comprising part or all of a conserved element within a Center-of-Tree (COT) sequence derived from a family of polypeptides encoded by naturally occurring variants of HIV. The invention also relates to immunogenic compositions and vaccines comprising said peptides. The invention also relates to methods for the identification of HIV controller patients based on the detection of the T cells of the patient to mount a cytotoxic T cell response against said peptides and to methods for the identification of immunogenic peptides within a family of variant polypeptides.
    Type: Application
    Filed: November 10, 2011
    Publication date: November 14, 2013
    Applicants: LABORATORIOS DEL DR. ESTEVE, S.A., UNIVERSITY OF WASHINGTON, INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS, FUNDACIÓ PRIVADA INSTITUT DE RECERCA DE LA SIDA - CAIXA
    Inventors: Beatriz Mothe Pujadas, Christian Brander, James I. Mullins